Vapaliximab Explained

Vapaliximab is a chimeric monoclonal antibody[1] and an experimental immunosuppressive drug. Development was discontinued by 2012.[2]

Notes and References

  1. https://web.archive.org/web/20091016232326/http://whqlibdoc.who.int/druginfo/INN_2003_list49.pdf WHO Drug Information
  2. Web site: Vapaliximab - AdisInsight . adisinsight.springer.com . 2 January 2019.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Vapaliximab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.